Clinical Trial Update: An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of INM-176 for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• INM-176

Snippet

Sponsor: Whanin Pharmaceutical Company | Conditions: Alzheimer Type Dementia | Phase 3 | Status: COMPLETED